The CanBiotech Newsletter:
Featuring News, Patient Engagement Blogs and Publications, Upcoming Events

Thanks for submitting!

Red ET Logo.png

 

 

Open-source approaches for the repurposing of existing or failed candidate drugs--Learning from and applying the lessons across diseases

Repurposing has the objective of targeting existing drugs and failed, abandoned, or yet-to-be-pursued clinical candidates to new disease areas. The open-source model permits for the sharing of data, resources, compounds, clinical molecules, small libraries, and screening platforms to cost-effectively advance old drugs and/or candidates into clinical re-development. Clearly, at the core of drug-repurposing activities is collaboration, in many cases progressing beyond the open sharing of resources, technology, and intellectual property, to the sharing of facilities and joint program development to foster drug-repurposing human-capacity development. A variety of initiatives under way for drug repurposing, including those targeting rare and neglected diseases, are discussed in this review and provide insight into the stakeholders engaged in drug-repurposing discovery, the models of collaboration used, the intellectual property-management policies crafted, and human capacity developed. In the case of neglected tropical diseases, it is suggested that the development of human capital be a central aspect of drug-repurposing programs. Open-source models can support human-capital development through collaborative data generation, open compound access, open and collaborative screening, preclinical and possibly clinical studies. Given the urgency of drug development for neglected tropical diseases, the review suggests elements from current repurposing programs be extended to the neglected tropical diseases arena.


Read More...

The CanBiotech Blog

Scientist

Patient Engagement Strategy
Spotlight

Empowering Patients through Technology: Using a Chatbot to address health concerns

Through a collaboration with Verily and Google, Penn Medicine was able to leverage machine learning and natural language processing to develop and launch an interactive tool to help patients get answers to their questions. Read more...

Image by Marianne Krohn

Upcoming Events

Health Courses on edX
Health Courses on edX
Future Pharma 2020
Future Pharma 2020

Future Pharma Boston Marriott Long Wharf, Boston, MA 14/09/2020 - 15/09/2020

15th CTIP
15th CTIP

15th Clinical Trials Innovation Programme Tel Aviv, Israel 15/09/2020 - 16/09/2020

11th DDIP
11th DDIP

11th Drug Discovery Innovation Programme Tel Aviv, Israel 15/09/2020 - 16/09/2020

6th PSIP
6th PSIP

6th Pharma Supply Chain & Logistics Innovation Programme Basel, Switzerland 01/10/2020 - 02/10/2020

4th MDIP
4th MDIP

4th Medical Devices Innovation Programme Boston, MA 07/10/2020 - 08/10/2020

12th DDIP
12th DDIP

12th Drug Discovery Innovation Programme Boston, MA 07/10/2020 - 08/10/2020

16th CTIP
16th CTIP

16th Clinical Trials Innovation Programme Boston, MA 07/10/2020 - 08/10/2020

17th CTIP
17th CTIP

17th Clinical Trials Innovation Programme San Francisco, CA 21/10/2020 - 22/10/2020

5th MDIP
5th MDIP

5th Medical Devices Innovation Programme an Francisco, CA 21/10/2020 - 22/10/2020

13th DDIP
13th DDIP

13th Drug Discovery Innovation Programme San Francisco, CA 21/10/2020 - 22/10/2020

18th CTIP
18th CTIP

18th Clinical Trials Innovation Programme Munich, Germany 16/11/2020 - 17/11/2020

14th DDIP
14th DDIP

14th Drug Discovery Innovation Programme Munich, Germany 16/11/2020 - 17/11/2020

7th PSIP
7th PSIP

7th Pharma Supply Chain & Logistics Innovation Programme Boston, MA 17/11/2020 - 18/11/2020

Pharmaceutical Compliance Congress Canada
Pharmaceutical Compliance Congress Canada

Pharmaceutical Compliance Congress Canada Montreal Airport Marriott Hotel, Montreal, Canada 17/11/2020 - 18/11/2020